A hybrid-capture assay to detect HPV mRNA ratios in cervical specimens

Journal of Virological Methods

Volumn 179, Issue 1, 2012, Pages 142-147

  Lowe, Brian ^a   Fulbright, Anna ^a   Nazarenko, Irina ^a  

^a QIAGEN North America   (United States)

Author keywords

Detection; E6 7:E2 ratio; Gene expression; Human papillomavirus

Indexed keywords

MESSENGER RNA;

ANALYTICAL PARAMETERS; ARTICLE; CANCER CELL; CELL LINE; CELL STRAIN CASKI; CELL STRAIN SIHA CELL; CONTROLLED STUDY; CROSS REACTION; DISEASE COURSE; DOWN REGULATION; E6 7 TO E2 RATIO; FEMALE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; HYBRID CAPTURE ASSAY; IN VITRO STUDY; LIMIT OF DETECTION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; VIRUS DETECTION;

BODY FLUIDS; CELL LINE; CERVIX UTERI; CROSS REACTIONS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; RNA, MESSENGER; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRULENCE FACTORS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84855238396     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.10.012     Document Type: Article

References (15)

1. Baker C.C., Phelps W.C., Lindgren V., Braun M.J., Gonda M.A., Howley P.M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 1987, 61:962-971.
2. Bosch F.X., Lorincz A., Munoz N., Meijer C.J.L.M., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 2002, 55:244-265.
3. Boshart M., Gissmann L., Ikenberg H., Kleinheinz A., Scheurlen W., zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 1984, 3:1151-1157.
4. Broder S. The Bethesda System for reporting cervical/vaginal cytologic diagnoses - report of the 1991 Bethesda Workshop. JAMA 1992, 267:1892.
5. Castle P.E., Dockter J., Giachetti C., Garcia F.A.R., McCormick M.K., Mitchell A.L., Holladay E.B., Kolk D.P. A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer. Clin. Cancer Res. 2007, 13:2599-2605.
6. Cullen A.P., Long C.D., Lorincz A.T. Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the hybrid capture II signal amplification probe test. J. Clin. Microbiol. 1997, 35:2275-2278.
7. Doorbar J. Papillomavirus life cycle organization and biomarker selection. Dis. Markers 2007, 23:297-313.
8. Lorincz A., Anthony J. A system for nucleic acid detection by signal amplification technology. Luminescence Biotechnology: Instruments and Applications 2002, 149-158. CRC Press, Boca Raton, FL. K. Van Dyke, C. Van Dyke, K. Woodfork (Eds.).
9. Molden T., Kraus I., Skomedal H., Nordstrom T., Karlsen F. PreTect™ HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. J. Virol. Methods 2007, 142:204-212.
10. Nazarenko I., Kobayashi L., Giles J., Fishman C., Chen G., Lorincz A. A novel method of HPV genotyping using hybrid capture sample preparation method combined with GP5+/6+ PCR and multiplex detection on Luminex XMAP. J. Virol. Methods 2008, 154:76-81.
11. Pett M.R., Herdman M.T., Palmer R.D., Yeo G.S.H., Shivji M.K., Stanley M.A., Coleman N. Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc. Natl. Acad. Sci. 2006, 103:3822-3827.
12. Sankaranarayanan R., Nene B.M., Shastri S.S., Jayant K., Muwonge R., Budukh A.M., Hingmire S., Malvi S.G., Thorat R., Kothari A., Chinoy R., Kelkar R., Kane S., Desai S., Keskar V.R., Rajeshwarkar R., Panse N., Dinshaw K.A. HPV screening for cervical cancer in rural India. N. Engl. J. Med. 2009, 360:1385-1394.
13. Smith J.A., White E.A., Sowa M.E., Powell M.L., Ottinger M., Harper J.W., Howley P.M. Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc. Natl. Acad. Sci. 2010, 107:3752-3757.
14. Vinokurova S., Wentzensen N., Kraus I., Klaes R., Driesch C., Melsheimer P., Kisseljov F., Durst M., Schneider A., Knebel Doeberitz M. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res. 2008, 68:307-313.
15. Zheng Z.-M., Baker C.C. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci. 2006, 11:2286-2302.